(Q83997410)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19495800%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

0 references

1 reference

title

Nephrotic syndrome and rituximab: facts and perspectives (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19495800%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

1 reference

Dagmar-Christiane Fischer

series ordinal

2

object named as

Dagmar-Christiane Fischer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19495800%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Dieter Haffner

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19495800%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

4 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19495800%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19495800%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19495800%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19495800%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

1433-1438

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19495800%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00467-009-1226-6

30 January 2020

exact match

0 references

cites work

Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome

1 reference

12 December 2020

Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome?

1 reference

12 December 2020

Rituximab: effective treatment for severe steroid-dependent minimal change nephrotic syndrome?

1 reference

12 December 2020

Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy

1 reference

12 December 2020

Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome

1 reference

12 December 2020

Rituximab therapy for steroid-dependent minimal change nephrotic syndrome

1 reference

12 December 2020

Rituximab for refractory focal segmental glomerulosclerosis

1 reference

12 December 2020

Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome

1 reference

12 December 2020

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

1 reference

12 December 2020

Does rituximab treat recurrent focal segmental glomerulosclerosis post-renal transplantation?

1 reference

12 December 2020

Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases

1 reference

12 December 2020

Disease recurrence in paediatric renal transplantation

1 reference

12 December 2020

Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment

1 reference

12 December 2020

Increased nitric oxide production by T- and B-cells in idiopathic nephrotic syndrome

1 reference

12 December 2020

Rituximab in patients with the steroid-resistant nephrotic syndrome

1 reference

12 December 2020

Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab

1 reference

12 December 2020

Evaluation and management of steroid-sensitive nephrotic syndrome

1 reference

12 December 2020

Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.

1 reference

12 December 2020

Rituximab therapy for childhood-onset systemic lupus erythematosus

1 reference

12 December 2020

Recent approaches to the pathogenesis of minimal-change nephrotic syndrome

1 reference

12 December 2020

Plasmapheresis-induced remission in otherwise therapy-resistant FSGS.

1 reference

12 December 2020

Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome-a randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische Nephrologie

1 reference

12 December 2020

Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse

1 reference

12 December 2020

Rituximab therapy in early recurrent focal segmental sclerosis after renal transplantation

1 reference

12 December 2020

Role of rituximab therapy in glomerulonephritis

1 reference

12 December 2020